Ausgabe 7/2019
Inhalt (18 Artikel)
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude Ferran, Pierre-Louis Toutain
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Maddalena Centanni, Dirk Jan A. R. Moes, Iñaki F. Trocóniz, Joseph Ciccolini, J. G. Coen van Hasselt
Pharmacology, Pharmacokinetics and Pharmacodynamics of Eculizumab, and Possibilities for an Individualized Approach to Eculizumab
Kioa Lente Wijnsma, Rob ter Heine, Dirk Jan A. R. Moes, Saskia Langemeijer, Saskia E. M. Schols, Elena. B. Volokhina, Lambertus P. van den Heuvel, Jack F. M. Wetzels, Nicole C. A. J. van de Kar, Roger J. Brüggemann
Interactions Between Antiepileptic and Antibiotic Drugs: A Systematic Review and Meta-Analysis with Dosing Implications
Carla Carnovale, Marco Pozzi, Faizan Mazhar, Giulia Mosini, Marta Gentili, Gabriëlla G. A. M. Peeters, Emilio Clementi, Sonia Radice
Physiologically Based Pharmacokinetic Modeling for Trimethoprim and Sulfamethoxazole in Children
Elizabeth J. Thompson, Huali Wu, Anil Maharaj, Andrea N. Edginton, Stephen J. Balevic, Marjan Cobbaert, Anthony P. Cunningham, Christoph P. Hornik, Michael Cohen-Wolkowiez
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children’s Oncology Group
Ryan J. Beechinor, Patrick A. Thompson, Michael F. Hwang, Ryan C. Vargo, Lisa R. Bomgaars, Jacqueline G. Gerhart, ZoAnn E. Dreyer, Daniel Gonzalez
Physiologically Based Pharmacokinetic Modelling of Hyperforin to Predict Drug Interactions with St John’s Wort
Jeffry Adiwidjaja, Alan V. Boddy, Andrew J. McLachlan
Impact of Ethnicity-Specific Hepatic Microsomal Scaling Factor, Liver Weight, and Cytochrome P450 (CYP) 1A2 Content on Physiologically Based Prediction of CYP1A2-Mediated Pharmacokinetics in Young and Elderly Chinese Adults
Guo-Fu Li, Qing-Shan Zheng, Yichao Yu, Wei Zhong, Hong-Hao Zhou, Furong Qiu, Guangji Wang, Guo Yu, Hartmut Derendorf
Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma
Li Yan, Bing Wang, Yen Lin Chia, Lorin K. Roskos
Comment on: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Patrick Nicolas
Authors’ Reply to Nicolas: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain
Comment on: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Joël Coste, Xavier Bertagna, Mahmoud Zureik
Authors’ Reply to Coste et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain
Comment on “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”
Alain Munafo, Axel Krebs-Brown, Sumedh Gaikwad, Bogumila Urgatz, Claire Castello-Bridoux
Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain
Comment on: Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?
Philippe Tréchot
Author’s Reply to Trechot: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”
Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, Pierre-Louis Toutain
Comment on “Target-Controlled Continuous Infusion for Antibiotic Dosing: Proof-of-Principle in an In-silico Vancomycin Trial in Intensive Care Unit Patients”
Iris K. Minichmayr, Markus Zeitlinger